Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-19-044238

Options or other derivatives

  • EVP, Chief Operating Officer acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SCHIERMEIER ANDREW EVP, Chief Operating Officer 2019-08-01 Grant or award · Stock Option (Right to Buy) +55,000 55,000 D
Loading xslF345X03/doc4.xml…